IPS Partners with AdhereTech to develop the first Internet of Things (IOT) pill bottle
Thousands of patients now using "smart" AdhereTech pill bottle to improve medication adherence.
Intelligent Product Solutions (IPS) partnered with AdhereTech to design and develop a "smart" pill bottle that reminds patients to take their medication. The AdhereTech Internet of Things pill bottle is now being used by thousands of patients, through major healthcare providers and pharmaceutical companies.
To increase medication adherence, the AdhereTech pill bottle can send a text message (to a patient or caregiver), light up, or play a song if patients forget to take their medication. AdhereTech is currently used by many top pharmaceutical companies and hospitals, and these innovative smart bottles improves medication adherence by an average of 20%.
For the design of the second generation AdhereTech "smart" pill bottle, AdhereTech worked with IPS to provide a full range of design services from prototype through manufacturing, including mechanical electrical and industrial design. From its first generation pill bottle to the second generation designed by IPS, the AdhereTech pill bottle needed to be an attractive, user-friendly and manufacturable.
"We selected IPS as our product design partner because of its full range of product design expertise, and in particular, its expertise in designing wireless products — our product essentially a pill bottle with the insides of a cell phone," said Josh Stein, CEO and Cofounder of AdhereTech. "IPS helped us to design and build the second generation product, which works globally and can be manufactured at scale. IPS also helped us improve the look and feel of the device, battery life and durability."
As part of the design process, IPS worked to create a power efficient design with more than 6 months of battery life, as the AdhereTech pill bottle needed to exceed a patient's prescription, without requiring battery recharging. In addition to product design, IPS facilitated preliminary regulatory reviews and shepherded the design through FCC regulatory testing.
"With the AdhereTech pill bottle, we designed a patient-friendly bottle that is packed with dense electronics, while working with such ease that it doesn't require the patient to connect to Internet, plug it in to charge it, or download any software — all of that is done automatically," said Mitch Maiman, President and Cofounder of Intelligent Product Solutions. "Working with AdhereTech was a true partnership, and we are thrilled to work with startups such as AdhereTech to help make their design concepts a success."
According to Stein, AdhereTech will manufacture more than 10,000 of its second generation "smart" pill bottles in 2016.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance